ILCT-1001

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameILCT-1001
Drug Alias NameILCT-1001
ClassificationOther
Mechanisms of ActionInterleukin-5 inhibitorsInterleukin-4 inhibitorsInterleukin-13 inhibitors +[5] 
TargetsInterleukin-17Tumor necrosis factor αInterleukin-4 +[5] 
Therapy Area/IndicationsPsoriasisDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsPsoriasisDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A